It is possible that the longer repeat threshold observed in MJD is due to a combination of wild-type ataxin-3 being neuroprotective, which is counteracted by the polyQ toxicity, and pathogenic ataxin-3 conserving some capacity to attenuate its own toxicity [162]. This evidence concerns the gene ATXN3 and Spinocerebellar ataxia type 3.